Bio-Techne President, Diagnostics and Genomics Segment, Kim Kelderman to Lead as CEO Effective February 1
Bio-Techne Corporation (NASDAQ:TECH) today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024. Dr. McManus succeeds Kim